REQUEST A DEMO
Total
USD $0.00
Search more companies

Innovative Shrimp Biotech Sdn. Bhd. (Malaysia)

Main Activities: All Other Animal Production
Full name: Innovative Shrimp Biotech Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Innovative Shrimp Biotech Sdn. Bhd. is an enterprise in Malaysia, with the main office in Seri Manjung. The enterprise operates in the All Other Animal Production industry. It was incorporated on November 16, 2015. The latest financial highlights indicate a net sales revenue increase of 9.72% in 2024. Over the same period, its total assets grew by 3.78%. In 2024, Innovative Shrimp Biotech Sdn. Bhd.’s net profit margin increased by 10.02%.

Headquarters
No. 132, Tingkat Bawah, Prsn Pm/1, Pusat Bandar Seri Manjung
Seri Manjung; Perak; Postal Code: 32040

Contact Details: Purchase the Innovative Shrimp Biotech Sdn. Bhd. report to view the information.

Basic Information
Registered Capital:
Purchase the Innovative Shrimp Biotech Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Innovative Shrimp Biotech Sdn. Bhd. report to view the information.
Incorporation Date:
November 16, 2015
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Innovative Shrimp Biotech Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
9.72%
Total operating revenue
9.72%
Operating Profit/Loss (EBIT)
62.91%
EBITDA
58.35%
Net Profit/Loss for the Period
63.33%
Total Assets
3.78%
Total Equity
-16.89%
Operating Profit Margin (ROS)
9.85%
Net Profit Margin
10.02%
Return on Equity (ROE)
25.73%
Quick Ratio
-0.3%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?